SA1661VHUP11
SA1661VHUP11
Almoosa Health Co.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.17B EUR | 5.27B EUR | 6.12B EUR | 7.77B EUR |
Enterprise Value | 6.54B EUR | 6.61B EUR | 7.06B EUR | 8.55B EUR |
Valuation Multiples | ||||
Trailing P/E | 26.32x | 26.94x | 27.2x | 38.54x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 3.45x | 3.52x | 4.25x | 7.11x |
Price to Book | 2.63x | 2.69x | 3.17x | 4.04x |
EV/Revenue | 4.37x | 4.41x | 4.9x | 7.82x |
EV/EBITDA | 22.12x | 20.55x | 22.02x | 33.89x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -12.04% | -12.32% | -7.31% | -3.77% |